U.S. market Closed. Opens in 6 hours 1 minute

RANI | Rani Therapeutics Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/A2.72M462.00K979.00K
Cost of Revenue822.00K1.31MN/AN/AN/A
Gross Profit-822.00K-1.31M2.72M462.00K979.00K
Operating Expenses66.10M63.45M54.32M17.01M28.04M
Selling, General & Admin26.48M26.84M27.83M4.96M3.46M
Research & Development39.62M36.61M26.48M12.04M24.58M
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-66.10M-63.45M-51.60M-16.54M-27.07M
Other Expenses / Income-1.78M177.00K-1.45M-124.00K478.00K
Before Tax Income-67.88M-63.27M-53.05M-16.67M-26.59M
Income Tax Expenses-33.91M70.00K41.00K35.00K10.00K
Net Income-33.97M-63.34M-53.09M-16.70M-26.60M
Interest Expenses5.08M1.07M466.00K124.00K10.00K
Basic Shares Outstanding25.50M23.82M19.71M19.74M19.74M
Diluted Shares Outstanding25.50M23.82M19.71M19.74M19.74M
EBITDA-65.28M-62.20M-51.51M-15.89M-26.08M
EBITDA Margin0.00%0.00%-1,895.84%-3,439.83%-2,663.74%
EBIT-62.80M-62.20M-52.58M-16.54M-26.58M
EBIT Margin0.00%0.00%-1,935.26%-3,580.95%-2,714.71%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙